Your browser doesn't support javascript.
loading
DUAL II China: Superior HbA1c reductions and weight loss with insulin degludec/liraglutide (IDegLira) versus insulin degludec in a randomized trial of Chinese people with type 2 diabetes inadequately controlled on basal insulin.
Pei, Yu; Agner, Bue R; Luo, Bin; Dong, Xiaolin; Li, Dongmei; Liu, Jun; Liu, Lei; Liu, Ming; Lu, Yibing; Nishida, Tomoyuki; Xu, Xiangjin; Mu, Yiming.
Afiliación
  • Pei Y; Department of Endocrinology, Chinese People's Liberation Army General Hospital, Beijing, China.
  • Agner BR; Bispebjerg Hospital, Copenhagen, Denmark.
  • Luo B; Novo Nordisk China Pharmaceuticals, Beijing, China.
  • Dong X; Department of Endocrinology, Jinan Central Hospital, Shandong University, Jinan, China.
  • Li D; Department of Endocrinology, Inner Mongolia People's Hospital, Hohhot, China.
  • Liu J; Department of Endocrinology, Fifth People's Hospital of Shanghai, Shanghai, China.
  • Liu L; Novo Nordisk A/S, Søborg, Denmark.
  • Liu M; Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China.
  • Lu Y; Department of Endocrinology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Nishida T; Novo Nordisk Pharma Ltd, Tokyo, Japan.
  • Xu X; Department of Endocrinology, Fuzhou General Hospital, Fuzhou, China.
  • Mu Y; Department of Endocrinology, Chinese People's Liberation Army General Hospital, Beijing, China.
Diabetes Obes Metab ; 23(12): 2687-2696, 2021 12.
Article en En | MEDLINE | ID: mdl-34387411
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Liraglutida Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Liraglutida Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2021 Tipo del documento: Article País de afiliación: China